These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9061801)

  • 1. Two-year outcome of elderly patients with anxious depression.
    Flint AJ; Rifat SL
    Psychiatry Res; 1997 Jan; 66(1):23-31. PubMed ID: 9061801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxious depression in elderly patients. Response to antidepressant treatment.
    Flint AJ; Rifat SL
    Am J Geriatr Psychiatry; 1997; 5(2):107-15. PubMed ID: 9106374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance treatment for recurrent depression in late life. A four-year outcome study.
    Flint AJ; Rifat SL
    Am J Geriatr Psychiatry; 2000; 8(2):112-6. PubMed ID: 10804071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of sequential antidepressant treatment on geriatric depression.
    Flint AJ; Rifat SL
    J Affect Disord; 1996 Jan; 36(3-4):95-105. PubMed ID: 8821312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of lithium augmentation in antidepressant-resistant geriatric depression.
    Flint AJ; Rifat SL
    J Clin Psychopharmacol; 1994 Oct; 14(5):353-6. PubMed ID: 7806693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year outcome of psychotic depression in late life.
    Flint AJ; Rifat SL
    Am J Psychiatry; 1998 Feb; 155(2):178-83. PubMed ID: 9464195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonresponse to first-line pharmacotherapy may predict relapse and recurrence of remitted geriatric depression.
    Flint AJ; Rifat SL
    Depress Anxiety; 2001; 13(3):125-31. PubMed ID: 11387732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of treatment on the two-year course of late-life depression.
    Flint AJ; Rifat SL
    Br J Psychiatry; 1997 Mar; 170():268-72. PubMed ID: 9229035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine.
    Cassano P; Soares CN; Cohen LS; Lyster AK; Fava M
    Arch Womens Ment Health; 2004 Jul; 7(3):167-71. PubMed ID: 15241662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.
    Altshuler L; Suppes T; Black D; Nolen WA; Keck PE; Frye MA; McElroy S; Kupka R; Grunze H; Walden J; Leverich G; Denicoff K; Luckenbaugh D; Post R
    Am J Psychiatry; 2003 Jul; 160(7):1252-62. PubMed ID: 12832239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
    J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine].
    Dalery J; Bouhassira M; Kress JP; Lancrenon S; Tafani A; Hantouche EG
    Encephale; 1995; 21(3):217-25. PubMed ID: 7649072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants.
    Flint AJ; Rifat SL
    Am J Psychiatry; 1999 Jun; 156(6):943-5. PubMed ID: 10360137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of lithium augmentation in an elderly cohort.
    Fahy S; Lawlor BA
    Int J Geriatr Psychiatry; 2001 Oct; 16(10):1004-9. PubMed ID: 11607947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic therapy with lithium in elderly patients with unipolar major depression.
    Wilkinson D; Holmes C; Woolford J; Stammers S; North J
    Int J Geriatr Psychiatry; 2002 Jul; 17(7):619-22. PubMed ID: 12112158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC
    Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.